Top Markets
Coin of the day
Vitrolife AB (publ) Vitrolife AB (publ)

Vitrolife AB (publ)

VITR
株式のランク #7830
Vitrolife AB (publ) is a medical technology company specializing in the... Vitrolife AB (publ) is a medical technology company specializing in the development, production, and global sale of products for assisted reproduction. Their comprehensive offering includes a variety of essential tools for fertility treatments, such as oocyte retrieval needles, sperm processing solutions, specialized in vitro fertilization media and oils, and micromanipulation pipettes. The company also provides general labware, incubators, cryopreservation products, and systems for preimplantation genetic testing. Furthermore, Vitrolife delivers advanced equipment, including the EmbryoScope and Primo Vision time-lapse systems, along with dedicated dishes and evaluation software for these platforms. Their technology portfolio extends to Octax laser and imaging systems, as well as environmental monitoring solutions like log and guard systems and wireless sensors. With its headquarters located in Gothenburg, Sweden, Vitrolife maintains a significant international presence, operating across Europe, the Middle East, and Africa; Asia; Japan and the Pacific; and both North and South America. Founded in 1994, the company was initially known as Scandinavian IVF Science before officially changing its name to Vitrolife AB (publ) in 1998.
株価
$10.67
時価総額
$1.44B
変化(1日)
-0.88%
変化(1年)
-26.53%
SE
取引 Vitrolife AB (publ) (VITR)

カテゴリー

Vitrolife AB (publ)(VITR)の利益
2026 時点の利益 TTM: 0
Vitrolife AB (publ) の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Vitrolife AB (publ) の利益の推移(2026 〜 2026)
各年末の利益
利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差
$7.51B -
US
$5.15B -
US
$5.56B -
IE
$3.86B -
US
- -
DE